Register Login

Keros Therapeutics Inc (KROS)

  • Event
  • May 18, 2022, 10:12 UTC

(10% Negative) Keros Therapeutics, Inc. (KROS) Announces Delay in observed Development Timeline Due to Pandemic-Related Challenges, Manufacturing Considerations, Safety Review

Full text
Register to leave comments
  • News bot Oct. 1, 2025, 8:49 p.m.

    📋 Keros Therapeutics, Inc. (KROS) - Clinical Trial Update

    Filing Date: 2022-05-18

    Accepted: 2022-05-18 06:12:09

    Event Type: Clinical Trial Update

    Event Details:

    Keros Therapeutics Inc (KROS) Announces Clinical Trial Update Keros Therapeutics Inc (KROS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: observed, reported
    • Clinical Stage: Clinical Trial, clinical trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges
    • Collaboration: Keros Therapeutics, Inc.

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Keros Therapeutics Inc
    • CIK: 0001664710
    • Ticker Symbol: KROS
    • Period End Date: 2022-05-18
    • Document Type: 8-K

Search

News categories